BioPharma Credit PLC (BPCR)

Currency in USD
0.862
-0.002(-0.23%)
Closed·

BPCR Financial Summary

Key Ratios

P/E Ratio8.86
Price/Book0.89
Debt / Equity0%
Return on Equity9.69%
Dividend Yield11.78%
EBITDA0.00
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.10%
Dividend Yield
11.78%
Industry Median 2.77%
Annualised payout
0.10
Paid unevenly
5-Years Growth
-
Growth Streak

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 0.000

Earnings

Latest Release
Mar 25, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
70.89M / --
EPS Revisions
Last 90 days

FAQ

What were BioPharma Credit's earnings for the latest quarter?

The BioPharma Credit EPS (TTM) is 0.10. BioPharma Credit reported sales of 70.89, net income of 50.34, and EPS of 0.04 for the latest quarter.

What was BioPharma Credit's net income for the latest quarter?

BioPharma Credit's net income for the latest quarter was 50.34.

How did BioPharma Credit's performance compare year-over-year in the latest quarter?

The company's revenue moved from 79.15 in the previous quarter to 70.89 in the latest quarter, and net income moved from 71.84 to 50.34 compared to the previous quarter.

What is BioPharma Credit's net profit margin on a TTM basis?

BioPharma Credit's trailing twelve months (TTM) net profit margin is 81.44%.

How does BioPharma Credit's debt to equity ratio compare to industry standards?

BioPharma Credit's total debt-to-equity ratio is 0.00%.

What is BioPharma Credit's return on investment on a TTM basis?

BioPharma Credit's trailing twelve months (TTM) return on investment (ROI) is 9.69%.

Did BioPharma Credit gain or lose cash last quarter?

In the latest quarter, BioPharma Credit's net change in cash was -31.52 million.

What were BioPharma Credit's total assets and liabilities in the latest quarter?

As of the latest quarter, BioPharma Credit reported total assets of 1,199.62 million and total liabilities of 17.88 million.

How has BioPharma Credit's total revenue grown this year?

BioPharma Credit's total revenue was 79.15 in the previous quarter and 70.89 in the latest quarter.

What is BioPharma Credit's gross margin on a TTM basis?

BioPharma Credit's trailing twelve months (TTM) gross margin is 100.00%.

What was BioPharma Credit's revenue per share for the latest quarter?

BioPharma Credit's revenue per share for the latest quarter was 0.51.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.